New hope for Never-Smokers with lung cancer: experimental drug combo targets resistant tumors
Disease control
Recruiting now
This study tests whether adding an experimental drug called LP-300 to standard chemotherapy can help people who never smoked but have advanced lung cancer that stopped responding to targeted therapy. About 90 participants will receive either the drug combo or chemo alone. The goa…
Phase: PHASE2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC